Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
Nanotechnology
|
April 7, 2010
Preparation and characterization of a magnetic and optical dual-modality molecular probe
A Bumb, C A S Regino, M R Perkins, et al.
Carcinogenesis
|
September 29, 2001
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator
R D Abeysinghe, B T Greene, R Haynes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model
K Tahtis, F T Lee, F E Smyth, et al.
Transplantation
|
December 1, 1992
Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factor
G L Parenteau, F M Dirbas, K Garmestani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2001
Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters
S V Govindan, D M Goldenberg, S E Elsamra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1994
Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies
L Camera, S Kinuya, K Garmestani, et al.
European Journal of Nuclear Medicine
|
July 1, 1994
Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA)
L Camera, S Kinuya, K Garmestani, et al.
Nuclear Medicine and Biology
|
September 3, 1999
Comparison of 225actinium chelates: tissue distribution and radiotoxicity
I A Davis, K A Glowienka, R A Boll, et al.
Biochemical Society Transactions
|
August 28, 2002
Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions
R P Planalp, A M Przyborowska, G Park, et al.
European Journal of Nuclear Medicine
|
June 18, 1998
In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand
D E Milenic, M Roselli, M W Brechbiel, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
Nanotechnology
|
April 7, 2010
Preparation and characterization of a magnetic and optical dual-modality molecular probe
A Bumb, C A S Regino, M R Perkins, et al.
Carcinogenesis
|
September 29, 2001
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator
R D Abeysinghe, B T Greene, R Haynes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model
K Tahtis, F T Lee, F E Smyth, et al.
Transplantation
|
December 1, 1992
Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factor
G L Parenteau, F M Dirbas, K Garmestani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2001
Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters
S V Govindan, D M Goldenberg, S E Elsamra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1994
Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies
L Camera, S Kinuya, K Garmestani, et al.
European Journal of Nuclear Medicine
|
July 1, 1994
Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA)
L Camera, S Kinuya, K Garmestani, et al.
Nuclear Medicine and Biology
|
September 3, 1999
Comparison of 225actinium chelates: tissue distribution and radiotoxicity
I A Davis, K A Glowienka, R A Boll, et al.
Biochemical Society Transactions
|
August 28, 2002
Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions
R P Planalp, A M Przyborowska, G Park, et al.
European Journal of Nuclear Medicine
|
June 18, 1998
In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand
D E Milenic, M Roselli, M W Brechbiel, et al.
Page
of 12